Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis
This article is from
The Cancer Letter
archive.
Vol. 25 No. 12 | December 27, 2002
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Hammer Says He’ll Demand Construction Funds If Data Supports The Need
August 12, 1983
TCL Archive
DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies
March 8, 1985
TCL Archive
Komen Deal With KFC Yields Buckets Of Discord
April 23, 2010
TCL Archive
Risk of Lymphoma Increases with Hepatitis C Virus Infection
May 25, 2007
TCL Archive
Kidney Cancer Group Seeks Proposals; AACR Offers Award
November 17, 1995
TCL Archive
Risk of Relapse Continues After Five Years of Therapy
August 29, 2008